Terms: = Colorectal cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Staging
277 results:
1. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
Rao C; Tong J; Yang Y
Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
[TBL] [Abstract] [Full Text] [Related]
2. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
[TBL] [Abstract] [Full Text] [Related]
3. colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract] [Full Text] [Related]
4. Novel Tumor Organoid-Based Mouse Model to Study Image Guided Radiation Therapy of Rectal cancer After Noninvasive and Precise Endoscopic Implantation.
Felchle H; Brunner V; Groll T; Walther CN; Nefzger SM; Zaurito AE; Silva MG; Gissibl J; Topping GJ; Lansink Rotgerink L; Saur D; Steiger K; Combs SE; Tschurtschenthaler M; Fischer JC
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):1094-1104. PubMed ID: 37875245
[TBL] [Abstract] [Full Text] [Related]
5. Optimising multiplex immunofluorescence staining for characterising the tumour immune micro-environment.
Cohen R; Lee-Pullen T; Miller TJ; Meehan K; Fuller K; McCoy MJ
Methods; 2023 Nov; 219():48-57. PubMed ID: 37741563
[TBL] [Abstract] [Full Text] [Related]
6. Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing.
Tejerina-Miranda S; Pedrero M; Blázquez-García M; Serafín V; Montero-Calle A; Garranzo-Asensio M; Julio Reviejo A; Pingarrón JM; Barderas R; Campuzano S
Bioelectrochemistry; 2024 Feb; 155():108571. PubMed ID: 37717337
[TBL] [Abstract] [Full Text] [Related]
7. High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers.
Lin JR; Chen YA; Campton D; Cooper J; Coy S; Yapp C; Tefft JB; McCarty E; Ligon KL; Rodig SJ; Reese S; George T; Santagata S; Sorger PK
Nat Cancer; 2023 Jul; 4(7):1036-1052. PubMed ID: 37349501
[TBL] [Abstract] [Full Text] [Related]
8. Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive colorectal cancer.
Lwin TM; Minnix M; Li L; Sherman A; Hong T; Wong JYC; Olafsen T; Poku E; Bouvet M; Fong Y; Shively JE; Yazaki PJ
Mol Imaging Biol; 2023 Aug; 25(4):727-734. PubMed ID: 37341873
[TBL] [Abstract] [Full Text] [Related]
9. [Poly-G for tumor matched samples chronicles the evolution of human colorectal cancer].
Gao X; Yu T; Zhang Q; Zhang SY; Huang D; Zhao XY; Liu G
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):382-388. PubMed ID: 37188622
[No Abstract] [Full Text] [Related]
10. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
[TBL] [Abstract] [Full Text] [Related]
11. Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry.
Lin W; Aluicio-Sarduy E; Houson HA; Barnhart TE; Tekin V; Jeffery JJ; Weichmann AM; Barrett KE; Lapi SE; Engle JW
Nucl Med Biol; 2023; 118-119():108329. PubMed ID: 36805869
[TBL] [Abstract] [Full Text] [Related]
12. Identification of Aging and Young Subtypes for Predicting colorectal cancer Prognosis and Immunotherapy Responses.
Tan L; Xiaohalati X; Liu F; Liu J; Fu H; Zhang Y; Gao J; Tao K; Wang G; Wang L; Wang Z
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675039
[TBL] [Abstract] [Full Text] [Related]
13. Implementation of a colorectal cancer screening intervention in Malaysia (CRC-SIM) in the context of a pandemic: study protocol.
Schliemann D; Ramanathan K; Ibrahim Tamin NSB; O'Neill C; Cardwell CR; Ismail R; Nanu P; Mohd Ghazali ANB; Kee F; Su TT; Donnelly M
BMJ Open; 2022 Sep; 12(9):e058420. PubMed ID: 36581978
[TBL] [Abstract] [Full Text] [Related]
14. Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients.
Castrogiovanni P; Barbagallo I; Imbesi R; Musumeci G; Sanfilippo C; Broggi G; Caltabiano R; Tibullo D; Giallongo C; Forte S; Li Volti G; Di Rosa M
Pathol Res Pract; 2022 Sep; 237():154038. PubMed ID: 35932496
[TBL] [Abstract] [Full Text] [Related]
15. HunCRC: annotated pathological slides to enhance deep learning applications in colorectal cancer screening.
Pataki BÁ; Olar A; Ribli D; Pesti A; Kontsek E; Gyöngyösi B; Bilecz Á; Kovács T; Kovács KA; Kramer Z; Kiss A; Szócska M; Pollner P; Csabai I
Sci Data; 2022 Jun; 9(1):370. PubMed ID: 35764660
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer.
Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M
J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964
[TBL] [Abstract] [Full Text] [Related]
17. Anal intraepithelial neoplasia screening in patients with human immunodeficiency virus infection.
Fernández Isart M; Serra Esteban J; Segura Sampedro JJ; Amengual Antich I; Martínez Ortega MA; Forteza Valades A; Riera Jaume M; González Argente FX
Rev Esp Enferm Dig; 2022 Dec; 114(12):713-718. PubMed ID: 35285660
[TBL] [Abstract] [Full Text] [Related]
18. Anal cancer in Sweden 2015-2019. Implementation of guidelines, structural changes, national registry and early results.
Johnsson A; Norman D; Angenete E; Cavalli-Björkman N; Lagerbäck C; Leon O; Lindh B; Lydrup ML; Nilsson MP; Perman M; Radu C; Zackrisson B
Acta Oncol; 2022 May; 61(5):575-582. PubMed ID: 35274596
[TBL] [Abstract] [Full Text] [Related]
19. Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling.
Gao LF; Zhong Y; Long T; Wang X; Zhu JX; Wang XY; Hu ZY; Li ZG
J Exp Clin Cancer Res; 2022 Mar; 41(1):81. PubMed ID: 35241150
[TBL] [Abstract] [Full Text] [Related]
20. Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancer.
Yan Y; Ding X; Han C; Gao J; Liu Z; Liu Y; Wang K
Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166370. PubMed ID: 35231545
[TBL] [Abstract] [Full Text] [Related]
[Next]
